Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> LUNG CANCER Latest News

MAR 28, 2014 - Health Canal

A Must Read - Share

Next-generation ALK Inhibitor Overcomes Resistance to Crizotinib in Lung Cancer

by AACR Communications Staff PHILADELPHIA —The targeted cancer drug crizotinib is very effective in causing rapid regression of a particular form of lung cancer, but patients’ tumors inevitably become resistant to the drug.

Tags: Next-generation ALK Inhibitor Overcomes Resistance to Crizotinib in Lung Cancer,  Lung Cancer Latest News